| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| SIEGALL CLAY B | President and CEO, Director | C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL | /s/ Sandra Stoneman, Attorney-in-Fact | 22 Dec 2025 | 0001167496 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IMNM | Common Stock | Purchase | $149,053 | +7,278 | +0.85% | $20.48 | 860,525 | 19 Dec 2025 | Direct | F1 |
| transaction | IMNM | Common Stock | Gift | $0 | -200,000 | -23% | $0.000000 | 660,525 | 19 Dec 2025 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | The weighted average purchase price for the transaction report was $20.48, and the range of prices were between $20.36 and $20.50, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |
| F2 | The Reporting Person gifted the shares of the Issuer's common stock to the Clay B. Siegall 2025 Grantor Retained Annuity Trust, of which the Reporting Person's brother is the trustee and the Reporting Person's children are the beneficiaries. The Reporting Person does not have or share investment control over these shares. |
| F3 | The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025 (the "Lock-Up Agreement"). The transferee has agreed to be bound by the terms of the Lock-Up Agreement. |